Strange 1.4 million-year-old fossil traced to previously unknown human relative 'nutcracker man‘
Researchers have believed since the 1960s that the fossil jaw, unearthed at the Swartkrans archaeological site, belonged to an early human species called Homo ergaster.
But new X-ray scans of the jaw and other fossils found at the site have helped create virtual 3D models that offer a better understanding of the internal and external structures of the extinct species.
The new findings, detailed in a study published in the Journal of Human Evolution, have led researchers to conclude that the jaw doesn't in fact belong to H ergaster.
It comes from a new species of the genus Paranthropus, nicknamed the 'nutcracker man' due to the fossil's massive size and huge molar teeth.
The researchers specifically assessed the fossil's dentine – the hard, dense, bony tissue that forms the bulk of a tooth below the enamel – and then compared it with those of other human relatives.
They found the fossil's teeth features differed from previously discovered specimens of the genus known as P aethiopicus, P boisei and P robustus.
'Altogether, the results show that SK 15 unambiguously falls outside the variation of H ergaster and that it's most compatible with the morphology of Paranthropus,' the researchers wrote in the study.
They categorised the fossil as belonging to a newfound species, which they named P capensis.
'We tentatively attribute SK 15 to Paranthropus capensis, a more gracile species of Paranthropus than the other three currently recognized species of this genus,' they said.
The newly discovered species 'very likely' split from P robustus over 2 million years ago.
This means at least two Paranthropus species – P robustus and P capensis – may have coexisted in the South African region 1.4 million years ago, likely inhabiting different ecological niches with varying diets.
The researchers called for further testing of preserved specimens of the genus Paranthropus to look for P capensis fossils mixed with them. 'The presence of other P. capensis specimens mixed among the current hypodigm of P robustus should be tested further, in particular by revising the fossil assemblages from Swartkrans,' they said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economist
5 days ago
- Economist
The War Room newsletter: How receiving aid became fatal in Gaza
New research shows it is being used for good and ill America has better technology. But will China adopt it more quickly? South African leftists dream of telling the West to get lost A guide to four special articles from our home for narrative journalism Its ruling that burning fossil fuels can be 'internationally wrongful' risks provoking a backlash American funding cuts are a catalyst for fresh thinking
Daily Mirror
27-07-2025
- Daily Mirror
Shark attack horror as boy, 7, has leg shredded in idyllic bay
A child suffered serious injuries after he was bitten on the arm and leg by a shark in Nuka Hiva, French Polynesia, before being airlifted to the main hospital in Tahiti A seven-year-old boy has been injured in a shark attack in French Polynesia, authorities have said. The fire department of Nuka Hiva, the largest of the Marquesas Islands, said about 10 children were playing and jumping in Taioha'e Bay when the incident happened on Friday. The boy was bitten on the arm and leg, according to local officials. A firefighter who helped the child with serious bite wounds said: "I'm 35 years old and this is the first time I've seen this. These were long and deep wounds." He added: "It's probably related to the fish carcasses that fishermen throw in this area. There are many sharks, such as blacktips, hammerheads, and lemon sharks." The child was taken to the island's small hospital before being airlifted to the French Polynesia hospital centre in Tahiti, which is located around 1,500km (930 miles) from Nuku Hiva. Shark attacks are rare in French Polynesia and are often linked to spearfishing, handling fish traps or feeding sharks, which is prohibited. The waters of French Polynesia were declared a shark sanctuary in 2006 and since then, populations have remained relatively healthy. A study carried out by a team of researchers from the Paris Science et Lettres (PSL) Research University found that when sharks bite humans in the area, it is mostly due to self-defence. The study, which reviewed over 60 years of shark bite data, found that in these cases, often triggered by harpooning, spear-gun strikes and rough handling, sharks typically inflict superficial wounds that are rarely fatal unless unfortunate circumstances, like arterial damage, occur. Last year, South African tourist Angus Kockott was bitten by a shark while freediving around the Gambier Island in French Polynesia. The shark approached him from behind a reef and took a bite on his arm, damaging his nerves and tendons. He said: "Seeing that shark right before it bit me – that was a real 'oh s**t' moment. My first reaction was to get my knife used for cutting lines, and I just went for the shark as hard as I could. "It was only a little knife, but I'm very glad I had it on that day. After it released my arm, I couldn't see anything except for a huge pool of blood around me, but I managed to stand up on a reef. My arm was literally squirting blood – it looked like a stripped drumstick." Angus said he was in "immense pain" but eventually recovered after being treated, and said he didn't blame the animal. The sailing enthusiast said: "It hasn't put me off being in the ocean – I can't wait until I can go back. My assumption was it was a territory thing – you can't blame the animal."
Reuters
25-07-2025
- Reuters
Health Rounds: RSV can boost seniors' heart risks
July 24 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up here.) Older adults hospitalized for respiratory syncytial virus (RSV) face an elevated risk of developing heart failure and a dangerous heart rhythm problem, a Canadian study found. The risk for heart failure was seen even in individuals without a history of heart problems, researchers reported in the Journal of the American Geriatrics Society, opens new tab. The researchers reviewed data on more than 100,000 adults aged 65 and older hospitalized in Ontario between 2011 and 2020 for either RSV, influenza, urinary tract infection, or a fracture. The proportion of patients with a subsequent cardiovascular event was 18.5% after an RSV-related hospitalization, compared to 17.7%, 12.1% and 8.4% after hospitalizations for influenza, urinary tract infection, or fracture, respectively. In comparisons of patients who were closely matched according to demographics and risk factors, heart failure (10%–11%) was the most common outcome for RSV patients, occurring in 10% to 11%. Next most common was the heart rhythm disorder atrial fibrillation, occurring in 5% to 6% of RSV patients. The risk for those outcomes, as well as for heart attack, 'was at least two to three times higher in patients with a pre-existing cardiovascular condition compared to those without,' the researchers also said. 'Our findings reinforce the importance of RSV vaccination in older adults and suggest that monitoring for signs of heart disease following an RSV illness may be pragmatic,' study leader Chris Verschoor of Health Sciences North Research Institute in Sudbury, Ontario, said in a statement. Sending dye through the small intestine to look for blockages has been sparing a significant proportion of patients from needing to undergo surgery, a new study shows. The dye, Gastrografin from Bracco Diagnostics Inc., is administered to symptomatic patients before an X-ray or CT scan so that surgeons can see the location and severity of any so-called adhesive small bowel obstructions. Researchers reviewed nationwide data on more than 20,000 patients with suspected small bowel obstruction managed in two periods - 2012 to 2016, before Gastrografin was widely used for this purpose, and 2019 to 2023, when using Gastrografin to visualize intestinal blockages was a standard of care. They found nearly a 45% decrease in surgeries for small bowel obstruction in the Gastrografin era, from 13,257 to 7,333. Small bowel obstruction accounts for 15% of hospital admissions in the U.S., with about 20% of cases needing surgery to reconstruct the intestine, the researchers said. The resulting healthcare costs total over $3 billion each year. Despite better small bowel obstruction outcomes overall, post-surgery mortality increased from 4.4% to 5.9% after use of the dye became standard, and reoperations within 30 days rose from 4.7% to 6.2% - likely because surgeries were probably more complex in the later era, the researchers said. Gastrografin testing had weeded out patients with relatively mild obstructions who ultimately didn't need surgery, they added. 'Previously, patients who had a relatively mild adhesive small bowel obstruction would have been operated on, as we didn't have an alternative option,' study leader Dr. Robert McLoughlin from the University of Connecticut School of Medicine in Farmington said in a statement. 'This meant that in the post-Gastrografin era, the surgeries were more complex and challenging, hence the increased morbidity and mortality.' Still, because surgeons have gotten better at managing patients after surgery for small bowel obstructions, patients in the Gastrografin group averaged 6 days in the hospital, versus about 10 days for patients treated before the Gastrografin era, the researchers reported in the Journal of Surgical Research, opens new tab. The current study was not designed to prove that any of the outcomes were the result of Gastrografin use, the article pointed out. McLoughlin recalled that during a discussion with a younger colleague about managing small bowel obstructions, he mentioned that when he was in training, surgeons operated 'on a lot more' of these patients. That recollection prompted the current study, he said. (To receive the full newsletter in your inbox for free sign up here)
